$545.08
Price
$42.9B
Market Cap
38.3
P/E Ratio
32.6
Forward P/E
$14.22
EPS (TTM)
—
Dividend Yield
$197M
Cash
$976M
Total Debt
79M
Shares Out
$518.55
$769.98
52-Week Range
Institutional Ownership of Idexx Laboratories Inc
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| 1.0M | $537M | — | — | ||
| 455 | $239530 | — | — |
Trading Activity for Idexx Laboratories Inc
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2026-Q2 | |||||
| SELL | -30.4% | 1.0M | $537M | $562.16 | |
| SELL | EXIT | — | — | $562.16 | |
| 2026-Q1 | |||||
| SELL | -21.9% | 1.5M | $824M | $641.37 | |
| BUY | +2.2% | 4.8K | $3M | $641.37 | |
| 2025-Q4 | |||||
| SELL | -28.1% | 1.9M | $1.3B | $689.93 | |
| BUY | +0.8% | 4.7K | $3M | $689.93 | |
| 2025-Q3 | |||||
| SELL | -1.1% | 2.6M | $1.7B | $637.86 | |
| BUY | +0.0% | 4.6K | $3M | $637.86 | |
| 2025-Q2 | |||||
| SELL | -0.3% | 2.6M | $1.4B | $504.83 | |
| SELL | -49.7% | 4.6K | $2M | $504.83 | |
| 2025-Q1 | |||||
| SELL | -0.6% | 2.6M | $1.1B | $429.03 | |
| BUY | +4.9% | 9.2K | $4M | $429.03 | |
| 2024-Q4 | |||||
| SELL | -0.1% | 2.7M | $1.1B | $432.11 | |
| BUY | +1.4% | 8.8K | $4M | $432.11 | |
| 2024-Q3 | |||||
| BUY | +0.0% | 2.7M | $1.3B | $483.39 | |
| BUY | +12.8% | 5.8K | $3M | $483.39 | |
| 2024-Q2 | |||||
| SELL | -1.9% | 2.7M | $1.3B | $499.30 | |
| 2024-Q1 | |||||
| SELL | -0.5% | 2.7M | $1.5B | $543.96 | |
| SELL | -3.0% | 5.1K | $3M | $543.96 | |
| 2023-Q4 | |||||
| SELL | -8.0% | 2.7M | $1.5B | $454.25 | |
| SELL | -6.2% | 5.3K | $3M | $454.25 | |
| 2023-Q3 | |||||
| BUY | +0.1% | 3.0M | $1.3B | $503.03 | |
| 2023-Q2 | |||||
| BUY | +0.2% | 3.0M | $1.5B | $482.12 | |
| BUY | +2.5% | 5.6K | $3M | $482.12 | |
| 2023-Q1 | |||||
| SELL | -14.2% | 3.0M | $1.5B | $481.32 | |
| SELL | -16.9% | 5.5K | $3M | $481.32 | |
| 2022-Q4 | |||||
| SELL | -4.9% | 3.4M | $1.4B | $404.80 | |
| SELL | -6.7% | 6.6K | $3M | $404.80 | |
| 2022-Q3 | |||||
| BUY | +0.1% | 3.6M | $1.2B | $369.66 | |
| 2022-Q2 | |||||
| BUY | +0.0% | 3.6M | $1.3B | $372.23 | |
| BUY | NEW | 7.1K | $2M | $372.23 | |
| 2022-Q1 | |||||
| SELL | -14.7% | 3.6M | $2.0B | $526.20 | |
| 2021-Q4 | |||||
| BUY | +0.0% | 4.2M | $2.8B | $625.66 | |
| 2021-Q3 | |||||
| SELL | -0.0% | 4.2M | $2.6B | $673.36 | |
| 2021-Q2 | |||||
| BUY | +0.5% | 4.2M | $2.7B | $549.35 | |
| 2021-Q1 | |||||
| SELL | -0.1% | 4.2M | $2.1B | $496.10 | |
| 2020-Q4 | |||||
| SELL | -0.1% | 4.2M | $2.1B | $453.64 | |
| 2020-Q3 | |||||
| SELL | -0.2% | 4.2M | $1.7B | $369.24 | |
| 2020-Q2 | |||||
| SELL | -0.1% | 4.2M | $1.4B | $294.32 | |
| 2020-Q1 | |||||
| SELL | -7.5% | 4.2M | $1.0B | $271.01 | |
| 2019-Q4 | |||||
| BUY | +0.8% | 4.6M | $1.2B | $261.60 | |
| SELL | EXIT | — | — | $261.60 | |
| 2019-Q3 | |||||
| BUY | +1.9% | 4.6M | $1.2B | $278.87 | |
| 2019-Q2 | |||||
| BUY | +0.1% | 4.5M | $1.2B | $247.83 | |
| 2019-Q1 | |||||
| BUY | +0.8% | 4.5M | $999M | $207.74 | |
| SELL | -28.0% | 1.1K | $256000 | $207.74 | |
| 2018-Q4 | |||||
| BUY | +0.1% | 4.4M | $1.1B | $202.34 | |
| 2018-Q3 | |||||
| SELL | -0.1% | 4.4M | $1.1B | $243.37 | |
| SELL | -11.0% | 1.6K | $397000 | $243.37 | |
| 2018-Q2 | |||||
| BUY | +0.0% | 4.4M | $965M | $204.56 | |
| BUY | +33.2% | 1.8K | $390000 | $204.56 | |
| 2018-Q1 | |||||
| BUY | +0.5% | 4.4M | $847M | $185.73 | |
Insider Trading for Idexx Laboratories Inc
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.